A Study of the Safety and Efficacy of CNTO 328 and Bortezomib to Bortezomib Alone in Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT00401843 · COMPLETED
Trial details
- NCT number
- NCT00401843
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-28
- Primary completion
- 2011-08-16
- Enrollment
- 307
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.